Kaye Scholer’s Life Sciences Group received two “Deal of the Year” accolades at the inaugural LMG Life Sciences Awards:
Merger & Acquisitions: Impact Deals of the Year - Novartis acquisition of Fougera
The firm represented Novartis on the purchase, by generics division Sandoz, of specialty dermatology generics company Fougera Pharmaceuticals for $1.525 billion in an all cash transaction. The acquisition made Sandoz the number one generic dermatology medicines company both globally and in the US.
Licensing & Collaboration Deal of the Year - TB Alliance agreement with Sanofi
The firm advised The Global Alliance for TB Drug Development (TB Alliance), an international non-profit organization which develops new, faster-acting, affordable tuberculosis drugs, in a research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis.
Kaye Scholer received an additional 15 nominations in 13 categories. The awards, based on independent research conducted by LMG Life Sciences earlier this year, were announced at an awards dinner held at New York’s Essex House on September 25.
Kaye Scholer’s Life Sciences Group previously received six practice recommendations in the 2013 edition of LMG Life Sciences, with an additional 13 lawyers selected as “Life Science Stars.”
Also of Interest
- Bloomberg Business: Moriarty Returns for “Taking Stock” ETFs & Bitcoin Podcast September 22, 2016 • Media Mentions
- O’Keefe Featured in the Daily Journal on the 2016 Proxy Season September 15, 2016 • Media Mentions
- Pro Bono Team Advances CodeEd’s Comp Sci Efforts for Coeds September 14, 2016 • Client Successes
- SEC Proposes Exhibit Hyperlink Requirements September 8, 2016 • Client Alerts
- Arbisser Featured in The Recorder and Law360... September 7, 2016 • Media Mentions
- Consumer Products: Adapting to Innovation Fall 2016 • Reports / Newsletters
- ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical September 2, 2016 • Client Successes
- Kaye Scholer Secures Dismissal of Merger-Related Class Action Against Baltic Trading September 1, 2016 • Client Successes
- Kaye Scholer Advises Veracen on Merger of Equals with Turner Investments August 31, 2016 • Client Successes